Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes

  1. Eshwar R Tammineni
  2. Natalia Kraeva
  3. Lourdes Figueroa
  4. Carlo Manno
  5. Carlos A Ibarra
  6. Amira Klip
  7. Sheila Riazi
  8. Eduardo Rios  Is a corresponding author
  1. Rush University, United States
  2. University of Toronto, Canada
  3. Toronto General Hospital, Canada
  4. The Hospital for Sick Children, Canada

Abstract

Most glucose is processed in muscle, for energy or glycogen stores. Malignant Hyperthermia Susceptibility (MHS) exemplifies muscle conditions that increase [Ca2+]cytosol. 42% of MHS patients have hyperglycemia. We show that phosphorylated glycogen phosphorylase (GPa), glycogen synthase (GSa) – respectively activated and inactivated by phosphorylation – and their Ca2+-dependent kinase (PhK), are elevated in microsomal extracts from MHS patients' muscle. Glycogen and glucose transporter GLUT4 are decreased. [Ca2+]cytosol, increased to MHS levels, promoted GP phosphorylation. Imaging at ~100 nm resolution located GPa at sarcoplasmic reticulum (SR) junctional cisternae, and apo-GP at Z disk. MHS muscle therefore has a wide-ranging alteration in glucose metabolism: high [Ca2+]cytosol activates PhK, which inhibits GS, activates GP and moves it toward the SR, favoring glycogenolysis. The alterations probably cause these patients' hyperglycemia. For basic studies, MHS emerges as a variable stressor, which forces glucose pathways from the normal to the diseased range, thereby exposing novel metabolic links.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures and tables in a multi-sheet Excel file

Article and author information

Author details

  1. Eshwar R Tammineni

    Physiology and Biophysics, Rush University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Natalia Kraeva

    Anaesthesia and Pain Management, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Lourdes Figueroa

    Physiology and Biophysics, Rush University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Carlo Manno

    Physiology and Biophysics, Rush University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Carlos A Ibarra

    Anaesthesia and Pain Management, Toronto General Hospital, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8898-6772
  6. Amira Klip

    Cell Biology Program, The Hospital for Sick Children, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7906-0302
  7. Sheila Riazi

    Anaesthesia and Pain Management, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Eduardo Rios

    Physiology and Biophysics, Rush University, Chicago, United States
    For correspondence
    erios@rush.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0985-8997

Funding

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR071381)

  • Sheila Riazi
  • Eduardo Rios

National Institute of Advanced Industrial Science and Technology (R01AR072602)

  • Eduardo Rios

National Institute of General Medical Sciences (R01GM111254)

  • Eduardo Rios

National Center for Research Resources

  • Eduardo Rios

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of Rush University (# 17-035, 16-091 and 18-065). All surgery was carried out on animals previously euthanized by methods approved under said protocols. Every effort was made to minimize stress and suffering.

Human subjects: Following approval by the institutional Research Ethics Board of Toronto General Hospital (TGH), informed consents were obtained from all patients who underwent the CHCT. The consent, also approved by the Institutional Review Board of Rush University, included use of biopsies for functional studies, imaging and cell culture.

Reviewing Editor

  1. Mark T Nelson, University of Vermont, United States

Publication history

  1. Received: November 27, 2019
  2. Accepted: May 4, 2020
  3. Accepted Manuscript published: May 4, 2020 (version 1)
  4. Version of Record published: June 9, 2020 (version 2)

Copyright

© 2020, Tammineni et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,257
    Page views
  • 238
    Downloads
  • 16
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eshwar R Tammineni
  2. Natalia Kraeva
  3. Lourdes Figueroa
  4. Carlo Manno
  5. Carlos A Ibarra
  6. Amira Klip
  7. Sheila Riazi
  8. Eduardo Rios
(2020)
Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes
eLife 9:e53999.
https://doi.org/10.7554/eLife.53999

Further reading

    1. Structural Biology and Molecular Biophysics
    Hirohide Takahashi, Toshiki Yamada ... Erkan Karakas
    Research Article Updated

    Volume-regulated anion channels (VRACs) mediate volume regulatory Cl- and organic solute efflux from vertebrate cells. VRACs are heteromeric assemblies of LRRC8A-E proteins with unknown stoichiometries. Homomeric LRRC8A and LRRC8D channels have a small pore, hexameric structure. However, these channels are either non-functional or exhibit abnormal regulation and pharmacology, limiting their utility for structure-function analyses. We circumvented these limitations by developing novel homomeric LRRC8 chimeric channels with functional properties consistent with those of native VRAC/LRRC8 channels. We demonstrate here that the LRRC8C-LRRC8A(IL125) chimera comprising LRRC8C and 25 amino acids unique to the first intracellular loop (IL1) of LRRC8A has a heptameric structure like that of homologous pannexin channels. Unlike homomeric LRRC8A and LRRC8D channels, heptameric LRRC8C-LRRC8A(IL125) channels have a large-diameter pore similar to that estimated for native VRACs, exhibit normal DCPIB pharmacology, and have higher permeability to large organic anions. Lipid-like densities are located between LRRC8C-LRRC8A(IL125) subunits and occlude the channel pore. Our findings provide new insights into VRAC/LRRC8 channel structure and suggest that lipids may play important roles in channel gating and regulation.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Sean M Braet, Theresa SC Buckley ... Ganesh S Anand
    Research Article Updated

    SARS-CoV-2 emergent variants are characterized by increased viral fitness and each shows multiple mutations predominantly localized to the spike (S) protein. Here, amide hydrogen/deuterium exchange mass spectrometry has been applied to track changes in S dynamics from multiple SARS-CoV-2 variants. Our results highlight large differences across variants at two loci with impacts on S dynamics and stability. A significant enhancement in stabilization first occurred with the emergence of D614G S followed by smaller, progressive stabilization in subsequent variants. Stabilization preceded altered dynamics in the N-terminal domain, wherein Omicron BA.1 S showed the largest magnitude increases relative to other preceding variants. Changes in stabilization and dynamics resulting from S mutations detail the evolutionary trajectory of S in emerging variants. These carry major implications for SARS-CoV-2 viral fitness and offer new insights into variant-specific therapeutic development.